Published in

Elsevier, International Journal of Infectious Diseases, (122), p. 628-635, 2022

DOI: 10.1016/j.ijid.2022.06.054

Links

Tools

Export citation

Search in Google Scholar

Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial

Journal article published in 2022 by Els Tobback ORCID, Sophie Degroote ORCID, Sabine Buysse, Liesbeth Delesie ORCID, Lucas Van Dooren ORCID, Sophie Vanherrewege ORCID, Cyril Barbezange ORCID, Veronik Hutse, Marta Romano ORCID, Isabelle Thomas, Elizaveta Padalko, Steven Callens ORCID, Marie-Angélique De Scheerder
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO